{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T19:24:12Z","timestamp":1698434652768},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":6202,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1992,5]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> The pretransplant alloantigen\u2010dependent responding and stimulating capacity of donors and of recipients was studied retrospectively, in a study of prediction of acute graft\u2010versus\u2010host disease. Donor responding capacity (DRC) and host stimulating capacity (HSC) were defined by mixed lymphocyte culture (MLC) and normalized by help of the pool response. High and low DRC and strong and weak HSC was defined by distribution plots. Kaplan\u2010Meier estimates of the risk of developing Grade I1 or higher aGvHD showed that first remission patients (N= 125) had a significantly different risk if transplanted with marrow from a donor with high (N = 54) or low (N = 71) DRC (\u03c7<jats:sup>2<\/jats:sup> = 9.49; d.f. = 1; p&lt;0.002). This was not the case for patients transplanted in later remissions. Host SC status had no significant influence on the aGvHD status (\u03c7<jats:sup>2<\/jats:sup> = 1.75 and 2.40; d.f. = 1; p = 0.19 and 0.12, defined by normal controls A and B respectively). In conclusion, the results indicate that pretransplant donor alloreactivity may predict aGvHD, confirming the results from a Scandinavian study. The results need to be confirmed in prospective studies of alloreactivity as risk factor for aGvHD.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1992.tb01802.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T11:47:24Z","timestamp":1279453644000},"page":"249-253","source":"Crossref","is-referenced-by-count":5,"title":["Donor alloreactivity may predict acute graft\u2010versus\u2010host disease in HLA\u2010matched bone marrow transplantation for leukemia in early remission"],"prefix":"10.1111","volume":"48","author":[{"given":"H. E.","family":"Johnsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. G.","family":"Beatty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. D.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197504172921605"},{"key":"e_1_2_1_3_2","first-page":"2600","article-title":"European experience of bone marrow transplantation for leukemia","author":"Ringden O.","year":"1987","journal-title":"Transplant Proc"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.tb06160.x"},{"key":"e_1_2_1_5_2","first-page":"365","article-title":"Bone marrow transplantation for acute non\u2010lymphocytic leukemia: a report from the Childrens Cancer Study Group of sixty\u2010seven children transplanted in first remission","volume":"02","author":"Feig SA","year":"1987","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_1_6_2","first-page":"243","article-title":"The treatment of acute non\u2010lymphoblastic leukemia by allogeneic marrow transplantation","volume":"2","author":"Clift RA","year":"1987","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"e_1_2_1_7_2","first-page":"7","article-title":"Predictive factors and prevention of acute graft\u2010versus\u2010host disease, the Seattle experience","volume":"3","author":"Storb R.","year":"1988","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.V71.2.293.293","article-title":"Cyclosporine v meth\u2010otrexate for graft\u2010v\u2010host disease prevention in patients given marrow grafts for leukemia: long\u2010term follow\u2010up of three controlled trials","volume":"71","author":"Storb R.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1985.tb01160.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198205000-00001"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198201143060202"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198804000-00018"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V66.3.664.664","article-title":"Effect of in vitro depletion of T cells in HLA\u2010identical allogeneic marrow grafts","volume":"66","author":"Martin P.","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92848-4"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V67.4.1172.1172"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-197410000-00001"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb02508.x"},{"key":"e_1_2_1_18_2","article-title":"Donor pretransplant cell mediated immune status may predict acute graft\u2010versus\u2010host disease in HLA\u2010matched bone marrow transplanted patients","author":"Johnsen HE","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_1_19_2","article-title":"A study of donor alloreactivity, which may predict acute graft\u2010versus\u2010host disease in HLA identical bone marrow transplantations for early leukemia","author":"Johnsen HE","journal-title":"Scand J Immunol"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1992.tb01802.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1992.tb01802.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T17:13:58Z","timestamp":1698081238000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1992.tb01802.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992,5]]}},"alternative-id":["10.1111\/j.1600-0609.1992.tb01802.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1992.tb01802.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,5]]}}}